Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Clinical trial NCT03575234 · WITHDRAWN

Trial details

NCT number: NCT03575234
Sponsor: Emory University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7

Start date: 2020-07-01
Primary completion: 2026-01-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.